Skip to content

The effect of oats fiber on glycemic control in Indian adults with type 2 diabetes.

Effect of oats containing -glucan supplementation on glycemic control in Indian adults with type 2 diabetes. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107362
Enrollment
140
Registered
2026-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: oats containing beta glucan: Daily 50 grms orally administered oats approximately provides 1.75 to 2.5 grms beta glucan for 3 months Control Intervention1: Roti make of atta: Daily dos

Sponsors

Lisa sarkar self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 20 to 60 years. Diagnosed with type 2 diabetes for more than 6 months. On stable antidiabetic drug regimen and no change for more than 6 months Baseline HbA1c 7 to 10 per cent BMI greater than 23 kg per meter square. According to the Endocrine Society of India, a BMI greater than 23 is considered overweight, and a BMI greater than 25 is considered obesity. Patient giving informed consent

Exclusion criteria

Exclusion criteria: Use of any extra supplement like psyllium or viscous fiber within 4 weeks. Significant renal eGFR less than 45, chronic liver disease, recent cardiovascular events, pregnancy and lactation. Any known history of GI malabsorption, inflammatory bowel disease . Known intolerance of oats or barley Patient refuses to give consent

Design outcomes

Primary

MeasureTime frame
1. Epidemiological data like Age, Sex, Address, Duration of diabetes, Current medications, Comorbidities hypertension, dyslipidemia 2. Clinical data like BMI, Waist circumference, waist: hip ratio, HbA1C, Lipid profile, ECG, Complete hemogram, AST, ALT or LFT Urine spot ACR. Timepoint: 12 weeks

Secondary

MeasureTime frame
Change in plasma glucose, insulin, lipid profile (TC, LDL, HDL, TG). Timepoint: From baseline to 12 weeks; Anthropometrics: weight, BMI, waist circumference. Hip circumferences, waist hip ratio.Timepoint: 120 weeks; Adverse events and tolerabilityTimepoint:

Countries

India

Contacts

Public ContactLisa Sarkar

School of Tropical Medicine

dr.arindam.naskar.83@gmail.com7044007741

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026